Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > They act like big pharma. That's a problem

<< Previous

Bullboard Posts

Next >>

Comment by Joemareon Jan 20, 2023 8:41am

178 Views

Post# 35235163

RE:RE:They act like big pharma. That's a problem

Well said. We don't even work for the company and we can clearly paint a clear picture of what's going on in there for the past three-four years. It's quite an accomplishment for this board. Our gift to them - they can skip paying another consultant doing a deep-dive in their business.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023